Hiv/aids news and hiv/aids widget

The FDA has granted PREZISTA (darunavir) tablets, a protease inhibitor, approval for an expanded indication for once-daily dosing as part of HIV combination therapy in treatment-naive adults (those who have never taken HIV medication before). The FDA also granted traditional (full) approval to PREZISTA as twice-daily for use in treatment-experienced adult patients. PREZISTA was developed by Tibotec Pharmaceuticals and is marketed in the U.S.

Half of the 2008 Nobel Prize in medicine will be shared by two researchers credited with their discovery of HIV. French researchers Luc Montagnier and Francoise Barre-Sinoussi will be honored...

At the 20th. Annual Living with AIDS Conference in Utah, experts warn that the booming crystal meth problem is contributing to new hiv cases around the country. The growing cocaine...

Loyola University researcher Dr. Michael Koller advises us all that now is the time to get your flu shot. Once you've had the flu it's not something you will soon...

A recent study published in The Lancet has found that the proportion of IV drug users that are HIV positive may exceed 40 percent in at least nine countries around...

On Friday, two Minnesota radio talk show hosts claimed that Magic Johnson faked his HIV diagnosis. The talk show hosts have rationalized that Magic must have faked his diagnosis because...

The Food and Drug Administration (FDA) has issued a warning against the use of a dietary supplement known as Xiadafil VIP. This supplement, sold over the counter, is commonly used...

Leading developer of RNA interference (RNAi)-based therapeutics Benitec Limited (ASX:BLT)(PINK:BNIKF) announced today that Dr John Zaia, had presented an update on the human HIV trial at the 2nd Annual Cambridge Healthtech Institute's "RNAi for Therapeutics" conference held in Boston, MA USA 22-23rd October 2008.

Anthony S. Fauci, M.D., will speak during the opening session of ICAAC/IDSA 2008, a joint meeting of the American Society for Microbiology and the Infectious Diseases Society of America, in Washington, DC. His keynote lecture at 4:30 p.m. on Saturday, Oct. 25, is titled Global health and Infectious Diseases: A Look to the Future. Dr. Fauci is director of the national institute of allergy and Infectious Diseases (NIAID), part of the National Institutes of health.

This is going to sound a bit crazy but I was watching television a couple nights ago and stumbled upon a vampire movie. Like all good Hollywood vampires, they were...